Abstract Submission Guidelines

Subpage Hero

Abstract Submission Guidelines

Information for Submitters
The ACMG Annual Clinical Genetics Meeting will be held from March 22 – 26, 2022 in Nashville, TN. This will be a hybrid meeting which means that attendees can participate onsite, stream sessions live or watch sessions on-demand.  Sixty (60) of the highest rated reviewed abstracts will become Platform Presentations and the remaining accepted abstracts will become ePosters. Attendees on site will have another option to hang their printed poster on a board in the exhibit hall (eposter upload is required). The goal of the ACMG annual meeting is to present new scientific research in all areas of genetics and genomics that provides attendees with knowledge and tools to take genetic discoveries and translate them into better patient care.

Important Dates

October 1, 2021 Online abstract submission site opens
November 19, 11:59 PM PT Deadline to submit an abstract(s)
Deadline to submit for an abstract award
December 13, 2021 Acceptance/Rejection Notification
Platform Presenter Assignments
December 22, 2021 Early Bird Registration Deadline
Deadline to Complete Platform Presenter Documents 
February 18, 2022 Abstract Withdrawal Deadline
February 28, 2022 Platform Presentation Slide Upload Deadline
ePoster upload with audio tour 
March 22-26, 2022 See you in Nashville, TN or online!

 

Abstract Presentation Types

During submission, submitters must choose one of the three submission types in which they would like the abstract considered for acceptance. The choice must be made at the time of submission and cannot be changed after the review committee has reached its decision.  

Submission options:

1. Poster Presentation Only

  •  Abstracts submitted for a poster presentation only will NOT be considered for a platform presentation, regardless of score.

2. Platform Presentation Only

  •  Abstracts submitted for a platform presentation only will NOT be considered for a poster, regardless of score. 

3. Platform or Poster Presentation

  •  Abstract will be considered as a platform or poster presentation, depending on score. 

Note: all posters must be uploaded as a pdf for ePoster presentation. Presenters attending the meeting in person must bring a paper poster for display on the poster boards.

Topic Categories

Research and/or studies must fit into one of the ACMG 2022 Abstract Categories.

1. Clinical genetics and therapeutics
2. Cancer genetics and therapeutics|
3. Biochemical and metabolic genetics
4. Laboratory genetics and genomics
5. Genetic counseling
6. Prenatal genetics
7. Public health, health services and implementation
8. Social, ethical and legal issues, education 

Responsibilities of the Submitter / Presenting Author

  • The submitting author is responsible for the following:
    o The submitter serves as point of contact for all correspondence regarding the abstract.
    o Ensuring that all authors have read the abstract and agreed to be co-authors. Failure to get approval from all authors will result in rejection of the abstract.
    o Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by ACMG.
    o Ensuring that all authors approve of submitting this work for presentation and publication.
    o Abiding by all formatting guidelines [insert URL]
     
  • The author(s) agree(s) to materially confine the presentation to information in the abstract, if accepted for presentation. If an author has more than one abstract accepted, each presentation will be materially confined to the information in the abstract selected for the specific session.
     

  • The presenting author will be available to present the abstract if selected for the program. The author(s) will immediately notify ACMG if the first author is not the presenting author.
     

  • The presenting author must be one of the co-authors listed on the submitted abstract. The presenting author must be confirmed prior to abstract submission.
     

  • An individual may be first author (i.e., presenting author) of more than one abstract. If the first author should have multiple accepted posters and has a conflict with the ePoster presentation schedule, then it is acceptable to designate one of the co- authors to present one of the posters. 

Authors' Consent and Waiver of Claims

Completion of all required information in the online abstract submission system serves as an agreement. It certifies the ACMG abstract submitter's understanding of the rules for participation contained in the online abstract submission program and affirms that:

• Each abstract author agrees and certifies that he or she:

    o has read all the rules and agrees to be bound by them,

    o is responsible for submission of the abstract in accordance with the rules, and

    o waives any and all claims against ACMG and any reviewer arising out of or relating to the abstract submission and review process, including but not limited to peer
       review and the grading of abstracts.

Abstract Submission Requirements

  • The abstract must address scientific questions, detail clinical observations, and/or contain primary scientific data. We encourage authors to highlight why their abstract is novel or how it provides a unique contribution or perspective.
  • Authors assign copyright of the abstract to ACMG upon submission, unless one of the authors is a U.S. Federal employee (in such case, ACMG does not hold copyright). This means that the identical abstract may not be republished or submitted to another meeting.
  • All research and studies reported in submitted abstracts that involve human and animal subjects must comply with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association.
  • Interim analysis of a prospective randomized clinical trial will be considered only if it is performed as planned in the original protocol and is statistically valid. If your abstract involves interim analysis, use the Interim Analysis of a Clinical Trial section of the abstract form to explain the details of your study. The reviewers will have this information available during their evaluation.
  • No revisions can be made after the abstract submission deadline (November 19, 2021).
  • The presentation at the annual meeting must reflect the submitted abstract. In particular, the abstract title, authorship, and scientific content of the presentation at the annual meeting must reflect the submitted abstract.
  • Abstracts should be written in clear and concise English, so that reviewers can focus solely on the scientific merits of the submission. We encourage non-English-speaking authors to have their abstracts checked for grammar and spelling prior to submission.
  • It is assumed that the presenting author will have adequate command of English to present and to respond to questions. If that is not the case, the authors should choose an (e)Poster as their preference.
  • Abstracts can be submitted if:

            - It is unpublished and original
            - Accepted for publication but not yet published
            - Encore presentations are allowed, only if material was previously presented at non-genetics meeting within the last 6 – 12 months.

Abstract Review and Selection Process

  • After the submission deadline, all completed and eligible abstracts will be made available to the ACMG Abstract Reviewers for review and scoring.
  • Abstracts will be evaluated and scored solely on their scientific merits.
  • Incomplete abstracts will not be reviewed.
  • Abstracts based on the same study with the same content reworded must not be submitted as multiple abstracts. Abstracts that are simply different versions of a single study will be rejected.
  • Abstracts will be peer reviewed according to the subject categories. Authors must indicate during online submission the appropriate review category (one only). All category selections will be final. There will be NO re-classification of abstracts after the abstract submission site has been closed. Abstracts submitted to an inappropriate category are scored in that category and may receive a lower score as a result.
  • All abstracts submitted will be considered eligible for one presentation format as explained above: either a platform or an poster. 
        o Platform Presentations are formal oral presentations (15 minutes total) that includes a brief discussion. Of the abstracts selected, four of the highest rated             will be featured in a special plenary session. For 2022 we expect this to be live on site in Nashville. However, we must remain flexible and may require                   presentations to be recorded following ACMG guidelines (to be sent later) by late January 2022. This serves multiple purposes of planning in advance of               potential meeting disruptions onsite. Additionally, platform presenters will need to follow standard presentation protocols with completion of recording                   release, HIPAA documentation, financial disclosure, and provision of learning objective and if an accredited session, a peer reviewed test question per                  guidelines (to be sent later). 
       o Poster Sessions allow the viewing of a printed poster illustration or ePoster of the abstract. Details regarding the audio tour recording of your ePoster, onsite        poster presentation, and other instructions will be provided in January 2022.

Acceptance / Rejection Notification

  • Notification regarding acceptance or rejection of abstracts will be sent to the submitting author the week of December 13, 2021 by email; consequently, an accurate email address is critical. If your abstract is accepted, the email will specify whether it is accepted as platform or ePoster presentation.
  • The abstract will then undergo formatting for publication in the abstract supplement to Genetics in Medicine. Authors are expected to format their abstracts according to these instructions prior to publication. Failure to format an abstract may result in it being omitted from the abstract supplement. 
  • The decision of the ACMG Program Committee regarding acceptance and presentation of abstracts is final.

Abstract Withdrawal

  • Once an abstract is accepted, a written request to withdraw must be submitted no later than February 18, 2022 to Education@ACMG.net if the first author decides to withdraw the abstract for any reason. Abstract withdrawal requests received after the deadline will be considered on a case-by-case basis. 
  • ACMG reserves the right to withdraw abstracts that are in violation of the College’s policies and guidelines, or GIM’s formatting guidelines, have been deemed scientifically unsound, or have been found to include inaccurate data, etc.
  • For any abstract submitters with non-withdrawn abstracts who do not fulfill their professional commitment of presenting at the meeting, ACMG reserves the right to consider this information in the selection of abstracts for presentation in the future.

Abstract Submission Policies

Platform Presenters Responsibility Regarding Financial Disclosure (ACCME Compliance)

       o The presenting author for a platform presentation will be contacted and must complete the online financial disclosure form and additional items pertaining to                   their presentation and participation. 

       o Employees of ACCME defined ineligible company may not present an accredited platform presentation. 

       o The content of the information with which you are involved will promote quality in health care or advances in science and will not promote a specific proprietary              or commercial interest. Content for this publication will be well-balanced and unbiased.

How to Submit an Abstract

The abstract submission site opens on October 1, 2021.

All abstracts must be submitted by Friday, November 19, 2021, 11:59 pm PT. Submissions that are incomplete by the deadline will be rejected.

  • Abstracts must be submitted online through the official online abstract submission system. Emails and word processing files not submitted through the site will not be accepted.
  • Once you have submitted the title page information, a draft of your abstract will be saved, and you will be able to return to edit and update it at any time until November 19, 2021, at 11:59 p.m., PT. You can log back into the abstract portal at www.acmgmeeting.net
  • For technical support please click on the "Feedback and Support" tab to the right of your screen. Technical support for Administrative Application users provided by phone and email during the hours of 9:00 am to 5:00 pm Central Time on regular working days (excluding weekends and holidays)

Preparing an Abstract for Submission

Please read the formatting guidelines before submission. Abstracts that are incorrectly formatted may be returned prior to review. 

Contact Information

  • Your name, degree, institution, address, phone number, and email address must be provided. As the corresponding author, you will receive all future correspondence from ACMG.
  • The submitting author should be the first author (presenter) of the abstract, unless otherwise noted during submission.

Co-Authors

  • Names of co-authors and institutions must be provided. Changes will not be made to the spelling of authors’ names after the submission deadline; please proof your co-authors’ names carefully. 

Copyright Policy

  • All authors must assign copyright of the abstract to ACMG, unless one of the authors is a U.S. Federal employee (in such case, ACMG does not hold copyright).

Abstract Title

  • The abstract title should be brief and clearly indicate the nature of the abstract. You may use up to 20 words.
  • The abstract title must be in title case. Capitalize all nouns, pronouns, adjectives, verbs, adverbs, and subordinate conjunctions (i.e., as, because, although). Except for the first word of the title, lowercase all articles, coordinate conjunctions (i.e., and, or, nor), and prepositions, regardless of length. Also, lowercase “to” when used as an infinitive. See examples here.
  • Additionally, keep letters lowercase if the lowercase letters have a specific meaning, such as aCGH or NIPS.
  • Do not put a period at the end of the title.
  • For example: Cancer Genetics: Translation of New Concepts to Clinical Care

Use of Product Names

  • Non-proprietary (generic/scientific) names should be used and should be lowercase.
  • If necessary, you may include a proprietary name in parentheses directly following the generic name after its first mention in the body of the abstract; the first letter of the name of a proprietary drug should be capitalized. ACMG reserves the right to replace proprietary names with generic names to adhere to this policy.

Abbreviations

  • Use standard abbreviations. Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract.

Terminology 

ACMG has preferred terminology that must be followed: 

We also require that all sequence variants follow HGVS nomenclature and that variants are classified as per the ACMG/AMP Guidelines.

Abstract Structure and Tables

  • Abstracts submitted for the ACMG annual meeting are published online. It is the responsibility of the author to proofread the abstract carefully.
  • You are allotted 1000 words for your abstract. The program will not allow submission if the maximum number is exceeded. 
  • The abstract must be structured (i.e., abstracts divided into sections using the terms Introduction, Methods, Results, Conclusions.). Case reports should follow this structure: Background, Case presentation, Conclusions. 
  • Do not use bold type or underline formatting. Italic type is acceptable.
  • Text may be in multiple paragraphs.
  • Special Greek and mathematical symbols are available in a character map within the submission system.
  • Use numerals to indicate numbers, except when beginning sentences.
  • A simple table in Excel may be uploaded in the online abstract submission system. This table will be placed below the abstract. 
  • Figures, diagrams, and images of patients should not be included
  • No references are allowed 

Abstract Awards (Geneticist - in -Training and Genetic Counselor)

David L. Rimoin Inspiring Excellence Award

The ACMG Foundation for Genetic and Genomic Medicine will award the David L. Rimoin Inspiring Excellence Award given to a selected student, trainee, or junior faculty ACMG member whose abstract submission in clinical genetics and therapeutics category is chosen as a platform presentation during the 2022 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, the Rimoin Fund will provide a cash award of $1,000 and cover the travel costs for the recipient to attend the meeting.

How to be considered for the David L. Rimoin Inspiring Excellence Award:

  • All geneticists-in-training, who are both first author and presenter of the abstract in clinical genetics and therapeutics category, are considered for an Abstract Award. Therefore, you must identify as a geneticist–in-training and then select the appropriate training category (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) in the online abstract submission system.
  • As a geneticist-in-training, you are required to submit a letter from the senior investigator overseeing your research confirming your status as a geneticist-in-training. The deadline for receipt of the geneticist-in-training letter is, therefore, November 19, 2021. There will be no exceptions.
  • Your letter must be typed on your institution’s letterhead, signed by the senior investigator, saved in PDF format, and uploaded to the online abstract submission system.
  • Please include the following items in your letter: Author name (this is the geneticist-in-training who is the presenting/contact author); Confirmation of your status as a geneticist-in-training
    •  Abstract Award recipients will be notified if they will receive an award the week of December 13, 2021. You must register and attend the meeting and present your abstract to receive your award.

Eligible candidates interested in entering the competition will indicate so during the abstract submission process.

Carolyn Mills Lovell Genetic Counselors Award 

ACMG supports special recognition and a Carolyn Mills Lovell Genetic Counselors award for a high-scoring abstract submitted by a genetic counselor.

The ACMG Foundation for Genetic and Genomic Medicine will be giving the Carolyn Mills Lovell Genetic Counselors Award to the first author of the highest rated genetic counselor-authored abstract submission for the scientific program during the 2022 ACMG Annual Clinical Genetics Meeting. 

How to be considered for the Carolyn Mills Lovell Genetic Counselors Award

The Carolyn Mills Lovell Genetic Counselors Award will be presented to the recipient at the 2022 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, a $1000 cash award will be given to the recipient. 

Applicants must be certified- or board-eligible Genetic Counselors or genetic counseling graduate students enrolled in an accredited genetic counseling training program and do not have to be an ACMG member.

Eligible candidates interested in entering the competition will indicate so during the abstract submission process.

Contact Information

Send related correspondence and questions regarding abstract submissions or notifications to Education@ACMG.net

ACMG Annual Meeting Registration and Housing www.acmgmeeting.net 

  • Please note that submitting an abstract does not register you for the ACMG annual meeting.
  • To register, you must complete and return an Attendee Registration Form, or register online through the ACMG Meeting website (www.acmgmeeting.net).